Tracker
CDSCO
87 notices, January 1 to December 30, 2024
Updated
How the drug, device and cosmetic rules work, from licences to trials: our CDSCO guide.
December 2024
- Notification regarding Banning Nimesulide for animal use, PDF, opens in a new tab
S.O. 5633(E) ·
- Submission of Clinical Trial Site Addition and change of Principal Investigator applications through SUGAM Portal, PDF, opens in a new tab
- Submission information of Immovable Property Return for the year 2024 through SPARROW Portal in r/o all employee of CDSCO (HQ), Zone, Sub-Zone, Lab and Ports offices, PDF, opens in a new tab
- Notification of Medical Device Testing Officers (MDTO) for Laboratories, PDF, opens in a new tab
S.O. 5331(E) ·
- Notification of MDTL (Surgical Gloves and Medical Examination Gloves)., PDF, opens in a new tab
S.O. 5330(E) ·
- Circular dated 09.12.2024 for the Shipment from foreign NRAs to India, PDF, opens in a new tab
- Reconstitution of Central Expert Committee to determine the quantum of compensation in respect of faulty ASR Hip implant manufactured by M/s. DePuy international Limited U.K now M/s. Johnson & Johnson Private Limited implanted in lndia, PDF, opens in a new tab
November 2024
October 2024
September 2024
- Circular regarding calculation of Income Tax for the Financial Year 2024-25, PDF, opens in a new tab
- Amendment for Government Analysts at CDL Kolkata, PDF, opens in a new tab
S.O. 4197(E) ·
- Notification for registration of Clinical Research Organisation CRO, PDF, opens in a new tab
From the draft G.S.R. 364(E) (PDF, opens in a new tab) of May 11, 2023
G.S.R. 581(E) ·
- Draft Guidelines on Good Clinical Practices, PDF, opens in a new tab
- Circulars dated 11.09.2024, PDF, opens in a new tab
- Baxter recall letter for Product Fibrin Sealant Kit Brand name Tisseel Lyo manufactured in Vienna Austria, PDF, opens in a new tab
August 2024
- Approved panel of experts for the Subject Expert Committees, PDF, opens in a new tab
- Prohibition of 156 FDCs, PDF, opens in a new tab
S.O. 3285(E), S.O. 3440(E) ·
- Restriction of FDC (Naproxen + Esomeprazole and Naproxen + Pantoprazole), PDF, opens in a new tab
S.O. 3266(E), S.O. 3267(E) ·
- Notification reg Prohibiton of Etodolac, PDF, opens in a new tab
S.O. 3284(E) ·
- Draft Guidelines on Good Distribution Practices for Pharmaceutical Products, PDF, opens in a new tab
- E-Governance Circular dated 09.08.2024, PDF, opens in a new tab
- Appointment of CPIO for the purpose of RTI Technical Matters 7 Aug 24, PDF, opens in a new tab
- Names of countries under the Rule 101 of New Drugs and Clinical Trial Rules 2019 related to new drug approval, PDF, opens in a new tab
- Implementation of Schedule M and WHO Technical Report Series, PDF, opens in a new tab
- Surrender of Cosmetics Import Registration Certificates of M/s Johnson & Johnson Pvt. Ltd L.B.S. Marg Mulund Mumbai Maharashtra India, PDF, opens in a new tab
July 2024
- Income Tax Circular regarding Tax regime and Savings dated 31..07.2024, PDF, opens in a new tab
- Circular regarding Requirement of Toxicity Studies for New Drugs SNDs and FDCs, PDF, opens in a new tab
- PRO feedback form Internal and Pro feedback form External, PDF, opens in a new tab
- Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945, PDF, opens in a new tab
Made final by G.S.R. 554(E) (PDF, opens in a new tab) of August 18, 2025
G.S.R. 391(E) ·
- Notification for No Advertisements of Drugs Specified in Schedule G under Drugs Rules, 1945, PDF, opens in a new tab
G.S.R. 375(E) ·
- Notification reg rules for Compounding of offences under D & C Act, PDF, opens in a new tab
Made final by G.S.R. 259(E) (PDF, opens in a new tab) of April 24, 2025
G.S.R. 374(E) ·
- Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 2nd and 4th July 2024 Meeting cancellation, PDF, opens in a new tab
May 2024
- Circular- Testing and evaluaion of Medical Devices In-Vitro Diagnostics by Medical Devices Testing Laboratory in the Country, PDF, opens in a new tab
- Inclusion of Cochin and Thiruvananthapuram Ports in Rule 43A of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 139(E) (PDF, opens in a new tab) of February 27, 2024
G.S.R. 293(E) ·
- Circular regarding The Blood Centre situated in Hospital based or Hospital Campus, PDF, opens in a new tab
- Appointment of CPIO and ACPIO (Nodal Officer) for the purpose of RTI Matters, PDF, opens in a new tab
- Withdrawal of indication for Olaparib Tablets 100mg and 150mg in the treatment of patient with gBRCA mutution and advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy, PDF, opens in a new tab
- Circular 16.05.2024 Digital Signature Certificate DSC is being used by CDSCO for signing the various online forms issuing NOCs through various online portals and digitally transmitted documents, PDF, opens in a new tab
- DTAB Sub-Committee to examine the proposal to regulate antibiotic and its irrational use date 16 may 2024, PDF, opens in a new tab
- Circular Regulation of all Class C & D Medical Devices under Licensing regime w.e.f 01.10.2023, as per G.S.R. 102(E) dt 11.02.2020, PDF, opens in a new tab
G.S.R. 102(E) ·
- Circular-Retention of license or certificates under Medical Devices Rules, 2017, PDF, opens in a new tab
- Circular on Medical Device related Adverse Events reporting by Medical Device Licence Holder under Materiovigilance Programme of India, PDF, opens in a new tab
- List of meetings of Expert Committee for examination of vaccine PSUR 2023-24, PDF, opens in a new tab
- Transfer order of CDSCO 2024, PDF, opens in a new tab
April 2024
- NOC's for manufacture of Unapproved/Banned/New Drugs Solely for Export Purpose, PDF, opens in a new tab
- Stakeholder consultation for feedback on SEC meetings dated 22.04.2024, PDF, opens in a new tab
- Manufacturing and marketing of unapproved drug Meropenam 1gm + EDTA for Injection, PDF, opens in a new tab
- Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 18 April 2024 Meeting cancellation, PDF, opens in a new tab
- Office Memorandum dated 12.04.2024 Grievance Redressal Officer for redressing the grievances of Persons with Disabilities under Section 23 of RPWD Act 2016 for CDSCO, PDF, opens in a new tab
- Public Notice regarding Draft CDSCO Guidance for Industry Version 1.2, PDF, opens in a new tab
- Public Notice regarding DCGI meeting with Stakeholders Dated 08.04.2024 for 16 April 2024 Meeting cancellation, PDF, opens in a new tab
- Implementation and effective use of RTI-MIS Portal (e-Portal) for disposal of all RTI including Physical RTI through RTI-MIS across all the CDSCO offices as per DoPT Order dated 12th August 2013 under RTI Act 2005, PDF, opens in a new tab
- Notice to All stakeholders for Strengthening of Private Medical Device Testing Laboratory, PDF, opens in a new tab
March 2024
- Implementation of Jan Vishwas (Amendment of Provisions) Act, 2023 related to Provisions of D & C Act, PDF, opens in a new tab
S.O. 1577(E) ·
- Circular Guidelines for risk based inspections of manufacturing facilities, PDF, opens in a new tab
- Public Notice regarding DCGI meeting with Stakeholders Dated 26.03.2024 for 28 march 2024 Meeting cancellation, PDF, opens in a new tab
- Meeting through WebEx Video-conference of the DTAB-sub Committee on 05.04.2024 at 11.00 a.m. to 6:00 p.m. to Evaluation of 16 FDCs which were earlier considered as irrational in the Expert Committee report of the Prof. Kokate Committee, PDF, opens in a new tab
- Circular regarding submission of PSUR of Medical devices/ IVD through Medical Devices Portal, PDF, opens in a new tab
- Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105, PDF, opens in a new tab
From the draft G.S.R. 687(E) (PDF, opens in a new tab) of September 25, 2023
G.S.R. 216(E) ·
- Office memorandum regarding to provide information in respect of reporting/reviewing officers for creation workflow and generating APAR, PDF, opens in a new tab
- Manufacturing and marketing of unapproved drug Meropenem & Disodium EDTA for Injection, PDF, opens in a new tab
- Public Notice regarding DCGI meeting with Stakeholders Dated 06.03.2024, PDF, opens in a new tab
February 2024
- Draft CDSCO Guidance for Industry: Post Approval Changes in Biological Products, PDF, opens in a new tab
- Notification of Bengaluru, Visakhapatnam, Cochin and Thiruvananthapuram Air Ports, PDF, opens in a new tab
Made final by G.S.R. 293(E) (PDF, opens in a new tab) of May 28, 2024
G.S.R. 139(E) ·
- Public Notice No. Admin-A012(12)/46/2024-eoffice dated 26.02.2024, PDF, opens in a new tab
- Circular regarding subbission of online applications of PSURs MA of New Drugs SNDs FDCs Biologicals Veterinary, PDF, opens in a new tab
- Circular Details of Cosmetics lmported by the Applicant Annually as per the Conditions of lmport Registration Number in Form Cos-4A under the Cosmetics Rules 2020, PDF, opens in a new tab
- Public Notice dated 15.02.2024, PDF, opens in a new tab
- Corrigendum dated 13 Feb 2024, PDF, opens in a new tab
- Online application for Neutral Code for manufacturing of Medical Devices for export purpose, PDF, opens in a new tab
- Regulatory guidelines for sampling of drugs cosmetics and medical devices by Drugs Inspectors of Central and State Drug Authorities, PDF, opens in a new tab
- Notification of Government Analysts for CDTL Indore, PDF, opens in a new tab
S.O. 567(E) ·
- Revoke of notification GSR 144(E) dated 17.02.2017 Oseltamivir and Zanamivir, PDF, opens in a new tab
S.O. 476(E), G.S.R. 144(E) ·
- Inclusion of Oseltamivir and Zanamivir in Schedule H1, PDF, opens in a new tab
From the draft G.S.R. 686(E) (PDF, opens in a new tab) of September 25, 2023
G.S.R. 95(E) ·
- Income Tax savings for FY- 2023-2024, PDF, opens in a new tab
- Notification of Government Analysts for NIB Noida, PDF, opens in a new tab
G.S.R. 91(E) ·
January 2024
- SEC-IND Office order dated 31.01.2024, PDF, opens in a new tab
- Appointment of First Appellate Authority & CPIO for the purpose of RTI (Technical) matters, PDF, opens in a new tab
- Office Order regarding senitization programme on PoSH (Prevention of Sexual Harassment), PDF, opens in a new tab
- Launching of additional Forms on National Single Window System NSWS Portal, PDF, opens in a new tab
- Month wise Tentative Schedule of SEC (Vaccine) meetings of the Year 2024, PDF, opens in a new tab
- Evaluation of certain pre 1988 permitted Fixed Dose Combinations FDCs de novo for manufacture for sale in the country without due approval from Central Licensing Authority, PDF, opens in a new tab
- PRO Details of Zonal, Sub zonal offices of CDSCO, PDF, opens in a new tab
- Submission of Information of Immovable Property Return for the year 2023 through e-HRMS 2.0 in respect of all employees of CDSCO(HQ) Zone Sub-Zone Lab and Port Offices, PDF, opens in a new tab
- Launching of National Single Window System (NSWS) Portal, PDF, opens in a new tab